DelistingJul 29, 2026, 04:18 PM
Celularity Receives Nasdaq Delisting Warning for Bid Price
AI Summary
Celularity Inc. received a notice from Nasdaq on July 23, 2026, indicating non-compliance with the minimum bid price requirement, as its Class A common stock traded below $1.00 for 30 consecutive business days. The company has 180 calendar days, until January 19, 2027, to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days. While the notice has no immediate effect on its Nasdaq listing, there is no assurance that Celularity will regain or maintain compliance, or secure an additional grace period.
Key Highlights
- Celularity received Nasdaq notice on July 23, 2026, for bid price non-compliance.
- Class A common stock traded below $1.00 per share for 30 consecutive business days.
- Company has 180 calendar days, until January 19, 2027, to regain compliance.
- Must achieve $1.00 closing bid price for 10 consecutive business days to comply.
- Notice has no immediate effect; stock continues to trade on Nasdaq as "CELU".
- May be eligible for an additional 180-day grace period if other listing rules met.
- No assurance of regaining or maintaining Nasdaq listing compliance.
Price Impact
More from CELU